PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)
Conditions
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Borderline Resectable Pancreatic Cancer
- Pancreatic Neoplasms
Interventions
- COMBINATION_PRODUCT: Gemcitabine Delivered by Transarterial Microperfusion
Sponsor
University of Vermont